Patents by Inventor Ivan V. Kuzmin

Ivan V. Kuzmin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160114026
    Abstract: Described herein are recombinant rabies viruses encoding rabies virus glycoprotein and at least one heterologous glycoprotein from another lyssavirus, such as Mokola virus, Lagos bat virus and/or West Caucasian bat virus. In particular embodiments, the recombinant rabies virus includes two or three heterologous lyssavirus glycoproteins. The disclosed recombinant rabies viruses can be used as pan-lyssavirus vaccines to provide protection against lyssaviruses that cause rabies.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 28, 2016
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Xianfu Wu, Charles E. Rupprecht, Ivan V. Kuzmin
  • Patent number: 9248179
    Abstract: Described herein are recombinant rabies viruses encoding rabies virus glycoprotein and at least one heterologous glycoprotein from another lyssavirus, such as Mokola virus, Lagos bat virus and/or West Caucasian bat virus. In particular embodiments, the recombinant rabies virus includes two or three heterologous lyssavirus glycoproteins. The disclosed recombinant rabies viruses can be used as pan-lyssavirus vaccines to provide protection against lyssaviruses that cause rabies.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: February 2, 2016
    Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventors: Xianfu Wu, Charles E. Rupprecht, Ivan V. Kuzmin
  • Publication number: 20130095137
    Abstract: Described herein are recombinant rabies viruses encoding rabies virus glycoprotein and at least one heterologous glycoprotein from another lyssavirus, such as Mokola virus, Lagos bat virus and/or West Caucasian bat virus. In particular embodiments, the recombinant rabies virus includes two or three heterologous lyssavirus glycoproteins. The disclosed recombinant rabies viruses can be used as pan-lyssavirus vaccines to provide protection against lyssaviruses that cause rabies.
    Type: Application
    Filed: June 23, 2011
    Publication date: April 18, 2013
    Applicant: The Government of the United States of America as Represented by the Secretary of the Department of
    Inventors: Xianfu Wu, Charles E. Rupprecht, Ivan V. Kuzmin
  • Patent number: 4290051
    Abstract: A device for reducing irrational-base codes to a minimal form, comprising "n" identical functional cells whereof each Bth cell incorporates a flip-flop with a count input and an AND convolution element intended to evaluate the possibility of performing the operation of convoluting the (B-1)th and (B-p-1)th code digits to the Bth code digit. One of the inputs of the AND convolution element is connected to an inverting output of the flip-flop whose direct output serves as an information output of the Bth functional cell. The flip-flop has its set, reset and count inputs connected to an information input, a convolution set input and an inversion signal input, respectively, of the Bth functional cell, the inversion signal input being connected to an information output of the (B-1)th functional cell. The remaining inputs of the AND convolution element are a first convolution signal input, a second convolution signal input and a convolution control input of the Bth functional cell.
    Type: Grant
    Filed: July 30, 1979
    Date of Patent: September 15, 1981
    Inventors: Alexei P. Stakhov, Andrei A. Kozak, Nikolai A. Solyanichenko, Ivan V. Kuzmin, Alexei D. Azarov